Page last updated: 2024-10-30

lorazepam and Cholera Infantum

lorazepam has been researched along with Cholera Infantum in 9 studies

Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.

Research Excerpts

ExcerptRelevanceReference
"The effectiveness of lorazepam was assessed under double-blind conditions in 70 ambulant patients suffering from anxiety associated with gastrointestinal symptomatology."9.04A clinical assessment of lorazepam in the treatment of anxiety associated with gastrointestinal symptomatology. ( Berkowitz, JM, 1978)
"The effectiveness of lorazepam was assessed under double-blind conditions in 70 ambulant patients suffering from anxiety associated with gastrointestinal symptomatology."5.04A clinical assessment of lorazepam in the treatment of anxiety associated with gastrointestinal symptomatology. ( Berkowitz, JM, 1978)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19909 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pandit, UA1
Kothary, SP1
Samra, SK1
Domino, EF1
Pandit, SK1
Kolde, G1
Czarnetzki, BM1
Kasich, AM1
Furtado, JD1
Baume, P1
Tracey, M1
Dawson, L1
Rider, JA1
Berkowitz, JM1
Richards, DJ1
Chaplan, A1
Vanov, SK1

Trials

6 trials available for lorazepam and Cholera Infantum

ArticleYear
[High-dosage metoclopramide versus lorazepam in cytostatic-induced gastrointestinal side effects].
    Deutsche medizinische Wochenschrift (1946), 1983, Sep-02, Volume: 108, Issue:35

    Topics: Anti-Anxiety Agents; Dacarbazine; Gastrointestinal Diseases; Humans; Lorazepam; Metoclopramide

1983
Lorazepam in the management of anxiety associated with chronic gastrointestinal disease: a double-blind study.
    Current therapeutic research, clinical and experimental, 1976, Volume: 19, Issue:3

    Topics: Adult; Aged; Anti-Anxiety Agents; Anxiety; Chronic Disease; Clinical Trials as Topic; Female; Gastro

1976
Lorazepam in gastrointestinal disorders with anxiety overlay.
    Psychosomatics, 1976, Volume: 17, Issue:1

    Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety; Clinical Trials as Topic; Drug Evaluation; Fe

1976
Efficacy of two minor tranquilizers in relieveing symptoms of functional gastrointestinal distress.
    Australian and New Zealand journal of medicine, 1975, Volume: 5, Issue:6

    Topics: Adult; Aerophagy; Aged; Anti-Anxiety Agents; Clinical Trials as Topic; Diazepam; Female; Gastrointes

1975
A clinical assessment of lorazepam in the treatment of anxiety associated with gastrointestinal symptomatology.
    The Journal of clinical psychiatry, 1978, Volume: 39, Issue:10 Pt 2

    Topics: Administration, Oral; Adolescent; Adult; Aged; Ambulatory Care; Anti-Anxiety Agents; Anxiety; Double

1978
GI illness: treatment of the anxiety component.
    Psychosomatics, 1977, Volume: 18, Issue:4

    Topics: Adolescent; Adult; Aged; Anxiety; Clinical Trials as Topic; Double-Blind Method; Female; Gastrointes

1977

Other Studies

3 other studies available for lorazepam and Cholera Infantum

ArticleYear
Physostigmine fails to reverse clinical, psychomotor, or EEG effects of lorazepam.
    Anesthesia and analgesia, 1983, Volume: 62, Issue:7

    Topics: Adult; Anti-Anxiety Agents; Brain; Cardiovascular Diseases; Double-Blind Method; Electroencephalogra

1983
Lorazepam in anxiety with GI disorders.
    Psychosomatics, 1977, Volume: 18, Issue:3

    Topics: Anti-Anxiety Agents; Anxiety; Double-Blind Method; Drug Evaluation; Female; Gastrointestinal Disease

1977
Clinical profile of lorazepam, a new benzodiazepine tranquilizer.
    The Journal of clinical psychiatry, 1978, Volume: 39, Issue:10 Pt 2

    Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aged; Anti-Anxiety Agents; Anxiety; Anxiety Di

1978